argenx Bags $231M in Upsized U.S. IPO Post author:Sam Post published:December 13, 2017 Post category:BioPharma argenx increased the Offering from the initially filed offering size of $150 million. Source: BioSpace You Might Also Like Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG™ and BOSULIF® February 22, 2018 Roche Faces Off With Itself for $9 Billion Breast Cancer Drug Business February 13, 2017 Hikma's Advair Generic Gets Further Delayed March 11, 2018
Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG™ and BOSULIF® February 22, 2018